Clinical and experimental hypertension : CHE

01 9 October 2026

DOI 10.1080/10641963.2026.2744634

Association between Chinese visceral adiposity index and prevalent hypertension among older adults in rural China: A cross-sectional study

Open DOI

Jian-Fang Zhang, Haiyan Lu, Xiangwei Ding et al.

02 2 October 2026

DOI 10.1080/10641963.2026.2731624

Efficacy and mechanistic insights of dapagliflozin in hypertension management

Open DOI

Zhongbo Chen, Wang Chunbin, Hanmei Zhang et al.

1. Hypertension affects more than one billion adults worldwide and remains one of the leading modifiable risk factors for cardiovascular disease, chronic kidney disease, and premature mortality. 1 ...

03 30 September 2026

DOI 10.1080/10641963.2026.2734004

Preliminary study of individualized therapy for ventricular septal defect with severe pulmonary arterial hypertension

Open DOI

Weijie Tang, Jinzhou Cai, Shibiao Zhang et al.

04 27 September 2026

DOI 10.1080/10641963.2026.2736024

Chemerin - CMKLR1 signaling contributes to immune metabolic dysfunction in salt-sensitive hypertension

Open DOI

Ronald McMillan, Mohammad Saleem, Ariel Thorson et al.

Hypertension is a multifactorial disease that extends beyond vascular and hormonal dysregulation. 1 While traditional models have emphasized vascular tone, fluid volume, and hormonal control, emerg...

05 10 September 2026

DOI 10.1080/10641963.2026.2728373

Electroacupuncture in hypertension-mediated organ damage: A hypothesis-generating framework of blood pressure-dependent and candidate blood pressure-independent mechanisms

Open DOI

Jing Pang, Kunpeng Xia, Yihong Ma

06 7 September 2026

DOI 10.1080/10641963.2026.2728372

Commentary on “The ApoB/ApoA-I ratio supersedes conventional lipids in predicting coronary artery disease and clinical phenotypes requiring revascularization”

Open DOI

Güney Sarıoğlu

Dear Editor,Jiang et al. provide a timely and clinically relevant evaluation of the apolipoprotein B to apolipoprotein A-I (ApoB/ApoA-I) ratio across several coronary artery disease phenotypes in a...

07 7 September 2026

DOI 10.1080/10641963.2026.2725928

Associations of antihypertensive medication class with liver fibrosis and mortality in US adults with MASLD

Open DOI

Yu Wu, Fei Fang

08 3 September 2026

DOI 10.1080/10641963.2026.2726549

Extracellular vesicles from the rostral ventrolateral medulla microenvironment regulate stress-induced hypertension via TNF-α-mediated modulation of neuronal excitability

Open DOI

Haisheng Liu, Xiaole Chang, Linping Wang et al.

1. Hypertension remains a critical global public health challenge. As reported in the WHO Global Hypertension Report 2023, approximately 1.3 billion people worldwide were living with hypertension i...

09 2 September 2026

DOI 10.1080/10641963.2026.2716134

Adipose-derived microRNA-518a drives hepatic cholesterol dysregulation and hypertension-related vascular remodeling in metabolic dysfunction-associated steatohepatitis via the MST1-AMPK-SREBP2 axis

Open DOI

Yu Xu, Sihan Zhang, Kun Wang et al.

Obesity is a chronic metabolic disease characterized by excessive adipose tissue accumulation and persistent metabolic imbalance arising from complex interactions among genetic, epigenetic, and env...

10 1 September 2026

DOI 10.1080/10641963.2026.2711737

Integrated multi-omics analyses identify an RAS–SLC11A2-associated molecular framework linking iron metabolism with PCOS-related cardiometabolic risk

Open DOI

Sihan Zhang, Yu Xu, Tingting Cao et al.

1. Polycystic ovary syndrome (PCOS) is a prevalent endocrine and metabolic condition that impacts around 10% of women of reproductive age globally. 1 , 2 Its main clinical features include menstrua...